Teen's Pancreatic Cancer Test Shows Promise in Study
Audrey Zheng, 17, developed a blood test detecting early-stage pancreatic cancer with 87% sensitivity and 87.5% specificity.
August 19, 2026
1 min read
27 views
Source: timesofindia.indiatimes.com
Image: timesofindia.indiatimes.com
Audrey Zheng, a 17-year-old student from Pennsylvania, has developed an innovative bioengineering method to detect early-stage pancreatic cancer from blood samples. Her test correctly identified 87% of patients with the disease and 87.5% of those without it, according to her research presented at a recent science competition.
Pancreatic cancer is notoriously difficult to detect early, often leading to late diagnoses and poor survival rates. Zheng's approach uses a novel biomarker panel that can distinguish early-stage pancreatic cancer from healthy controls with high accuracy.
Her work has garnered attention from the scientific community for its potential to improve early detection and patient outcomes. Further validation in larger clinical trials is needed before the test can be widely used.
β Frequently Asked Questions
What is the accuracy of Audrey Zheng's pancreatic cancer test?
The test correctly identified 87% of pancreatic cancer patients and 87.5% of healthy individuals.
Why is early detection of pancreatic cancer important?
Early detection significantly improves survival rates, as pancreatic cancer is often diagnosed at advanced stages when treatment options are limited.
Is this test available for clinical use?
No, further validation in larger clinical trials is required before it can be widely used in medical practice.
